Quantcast
Last updated on April 16, 2014 at 12:01 EDT

Latest Drugs Stories

2014-03-13 16:27:31

NSC warns against improper prescription painkiller use during National Poison Prevention Week ITASCA, Ill., March 13, 2014 /PRNewswire-USNewswire/ -- Our nation's most abused drug is legal and sitting in the medicine cabinet. Fatal drug overdoses are an epidemic, with opioid prescription painkiller overdoses accounting for the majority of these deaths. http://photos.prnewswire.com/prnvar/20140313/DC83026-INFO In observance of National Poison Prevention Week (March 16-22), the National Safety...

2014-03-13 12:29:23

Cardinal Health Foundation, The Ohio State University College of Pharmacy Release Fifth Generation Rx Toolkit to Educate Youth DUBLIN, Ohio, March 13, 2014 /PRNewswire/ -- According to a recent study conducted by Safe Kids Worldwide, more than 67,000 children were treated in emergency departments for medicine poisoning in 2011. The increased accessibility of prescription and over-the-counter medicines, coupled with children's natural curiosity, makes it important to educate today's youth in...

2014-03-13 08:29:59

MUNICH, March 13, 2014 /PRNewswire/ -- Formycon AG has expanded its Advisory Board. With Dr. Bernhard Hampl, a top pharmaceuticals manager from the US has been acquired for the advisory body. Over the past 20 years, Dr. Bernhard Hampl was a successful CEO in large American generics companies such as EON LABS Inc. and later Sandoz US, which after fusion of the two companies became America's second-largest manufacturer of generics. Dr. Hampl, who started his...

2014-03-13 08:29:40

People with Inadequate or Not Enough Lashes Can Grow Their Own Lashes with LATISSE® (bimatoprost ophthalmic solution) 0.03%, the only FDA-Approved Treatment for Growing Eyelashes Longer, Fuller and Darker in 16 weeks IRVINE, Calif., March 13, 2014 /PRNewswire/ -- According to a new U.S. survey conducted by Wakefield Research on behalf of Allergan, Inc., maker of BOTOX® Cosmetic (onabotulinumtoxinA), three out of four women (n = 500) have admitted to having concerns about their inadequate...

2014-03-12 08:29:55

MUNICH, March 12, 2014 /PRNewswire/ -- - The long-term orientation of Formycon AG as a global biosimilar developer has been successfully achieved. The company ended the year 2013 with the out-licensing of the first development project. - With Carsten Brockmeyer, Gerhard Schaefer and Simon Sturge, Formycon has appointed experienced pharma managers to the board of directors and the advisory board. -...

2014-03-09 23:03:16

Aid in Recovery released a statement today commenting on a recent statement from Gil Kerlikowske, Director of the Office of National Drug Control Policy. Kerlikowske issued a statement urging more local police and fire departments to equip officers with naloxone, a drug used to reverse the effects of heroin overdoses. Stuart, Florida (PRWEB) March 09, 2014 Aid in Recovery, full service drug and alcohol rehabilitation center servicing South Florida, released a statement today commenting on...

2014-03-07 23:25:22

http://www.DrugNews.net is the web’s premier source for prescription device warnings, research, side effects and legal news. Visit the DrugNews Center today. Chicago, IL (PRWEB) March 07, 2014 The prescription drug safety center DrugNews.net is announcing updated information on the site for patients taking testosterone replacement therapies, or “low-T” drugs. A new study concludes the current testing methods may result in inaccurate prescription levels of the drugs*. The report...

2014-03-07 12:25:21

In Addition, Company Also Wins Runner-Up In Best Packaging Award For New ActiPatch® Therapy Box FREDERICK, Md., March 7, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices won citations in two award categories from the OTC Bulletin, the leading global trade publication for over-the-counter healthcare products. The Smart Insole(TM) Heel Pain Therapy product was highly commended as the "Most Innovative New OTC Product...

2014-03-06 12:27:02

ORLANDO, Fla., March 6, 2014 /PRNewswire/ -- TNI BioTech, Inc. (OTC: TNIB) announced today that it has formed a new subsidiary, Cytocom, Inc., for the purpose of developing Low Dose Naltrexone (LDN) and Met-enkephalin (MENK). TNI BioTech has spent the last year developing a manufacturing and distribution network for sale of LDN into emerging nations and has had discussions with the FDA and EMA to begin clinical trials in the United States. The Company has considered whether to...

Physicians A Leading Source For Opioid Drug Abuse
2014-03-04 10:11:28

Brett Smith for redOrbit.com - Your Universe Online A new study from researchers at the Centers for Disease Control and Prevention (CDC) has found that most people who abuse prescription painkillers get their fix from friends and family, while those who chronically abuse the addictive opioids most likely get the drugs from their own doctor. Published in the Journal of the American Medical Association Internal Medicine, the new study emphasizes the need for mitigation efforts that target...